Liminatus Pharma, Inc. (LIMN) - Latest Market Data

Price & Market Data

Price: $0.164

Daily Change: -$0.0825 / 50.46%

Daily Range: $0.133 - $0.22

Market Cap: $7,602,271

Daily Volume: 26,448,558

Performance Metrics

1 Week: -9.75%

1 Month: -19.02%

3 Months: -28.75%

6 Months: -81.05%

1 Year: -97.36%

YTD: -74.42%

About Liminatus Pharma, Inc. (LIMN)

Essential market overview for Liminatus Pharma, Inc. (LIMN). Current price: 0.164, daily change: -$0.0825 / 50.46%. Market cap: 7,602,271. All key performance metrics for a full analysis.

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Selected stocks

EZGO Technologies Ltd. (EZGO)

Longeveron Inc. (LGVN)

Diginex Limited (DGNX)

Virgin Galactic Holdings, Inc. (SPCE)